This article features interviews with leading experts who discuss the impact of DNA methylation in biological processes involved in development and aging and disease states like cancer and neurological disorders.
Expert panel:
- Per Hoffman (Life & Brain Genomics; Germany)
- Robert Hillary (University of Edinburgh; UK)
- Jörg Tost (Centre National de Recherche en Génomique Humaine; France)
Learn more about:
- Impact of aberrant DNA methylation and demethylation across various diseases
- Sample considerations for measurement of CpG sites using methylation arrays
- Advice for someone embarking on a DNA methylation study for the first time
Download the article today.
Image Credit: Illumina, Inc
About Illumina, Inc
At Illumina, our goal is to apply innovative technologies to the analysis of genetic variation and function, making studies possible that were not even imaginable just a few years ago. It is mission critical for us to deliver innovative, flexible, and scalable solutions to meet the needs of our customers. As a global company that places high value on collaborative interactions, rapid delivery of solutions, and providing the highest level of quality, we strive to meet this challenge. Illumina's innovative sequencing and array technologies are fueling groundbreaking advancements in life science research, translational and consumer genomics, and molecular diagnostics.
Sponsored Content Policy: News-Medical.net publishes articles and related content that may be derived from sources where we have existing commercial relationships, provided such content adds value to the core editorial ethos of News-Medical.Net which is to educate and inform site visitors interested in medical research, science, medical devices and treatments.